The approval was based on additional efficacy data from the ACCESS IUS trial. The Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Liletta ® ...
Intrauterine devices (IUDs) are one of the most effective and low-maintenance forms of birth control available, with a ...
At Ahuja Medical Center, we are conducting a clinical trial to evaluate the safety and effectiveness of an investigational device designed to prevent the development of intrauterine adhesions (scar ...
SAN FRANCISCO, Nov. 14, 2022 /PRNewswire/ -- Medicines360, a global nonprofit organization with a mission to expand women's access to quality medicines, announced today that the U.S. Food and Drug ...
Newly-designed hormone-free IUD was successful for preventing pregnancy at 3 years. Placement success was high for both nulliparous and parous participants, and clinicians and users reported positive ...